BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8385653)

  • 21. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8- thymocytes.
    Suda T; Zlotnik A
    J Immunol; 1991 May; 146(9):3068-73. PubMed ID: 1826704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitogenic effect of PMA + IL 2 on subpopulations of corticoresistant thymocytes.
    Dupuy d'Angeac A; Monis M; Rème T
    J Immunol; 1986 Dec; 137(11):3501-8. PubMed ID: 3097124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulation of immunological balance between TH1/TH2 and Tc1/Tc2 lymphocytes by prostaglandin E2].
    Bao YS; Wang M; Zhang P; Zhou Z; Zhai WJ; Wang H; Jiang EL; Huang Y; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):431-5. PubMed ID: 20416182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of PGE2 upon differentiation and programmed cell death of suspension cultured CD4-CD8- thymocytes.
    Saiagh S; Rigal D; Monier JC
    Int J Immunopharmacol; 1994 Sep; 16(9):775-86. PubMed ID: 7806436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
    Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
    Vandenberghe P; Ceuppens JL
    Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event?
    Diamantstein T; Klos M; Reimann J
    Immunology; 1981 May; 43(1):183-9. PubMed ID: 6972903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf.
    Hooper KM; Kong W; Ganea D
    PLoS One; 2017; 12(6):e0179184. PubMed ID: 28604806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of thymocyte proliferation by alpha beta TcR+ CD3+ CD4- CD8- cloned natural suppressor (NS) cells.
    Van Vlasselaer P; Fischer M; Strober S; Zlotnik A
    Cell Immunol; 1991 Aug; 136(1):1-15. PubMed ID: 1829396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 4 and interferon gamma production in restimulated CD4+ and CD8+ cells indicates memory type responsiveness.
    Sander B; Cardell S; Möller E
    Scand J Immunol; 1991 Mar; 33(3):287-96. PubMed ID: 1826374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
    Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
    Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-7 induces proliferation of CD3-/low CD4- CD8- human thymocyte precursors by an IL-2 independent pathway.
    Fabbi M; Groh V; Strominger JL
    Int Immunol; 1992 Jan; 4(1):1-5. PubMed ID: 1531763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressed proliferative response and interleukin-2 production in hispanic HIV+ and AIDS T-cell subsets.
    Eylar EH; Báez I; Vázquez A; Colón-Martínez SL; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S25-33. PubMed ID: 8574145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
    Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
    J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prostaglandin E2 and other intracellular cyclic AMP elevating agents on the mitogen induced mouse splenocyte proliferation in a serum free culture condition.
    Zhong WW; Chavali SR; Forse RA
    Life Sci; 1994; 55(11):PL193-8. PubMed ID: 8072381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation by PGE2 of IL-2, IL-3 and IFN production by cortico-resistant thymocytes.
    Daculsi R; Vaillier D; Gualde N
    Immunol Lett; 1993 Nov; 38(3):229-35. PubMed ID: 7510266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset.
    Baseta JG; Stutman O
    J Immunol; 2000 Nov; 165(10):5621-30. PubMed ID: 11067918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacologic regulation of interleukin-1 production: the role of prostaglandins.
    Otterness IG; Bliven ML; Eskra JD; Reinke M; Hanson DC
    Cell Immunol; 1988 Jul; 114(2):385-97. PubMed ID: 2968844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.